NB
NovaBridge Biosciences (NBP)
NASDAQ·Healthcare·Biotechnology
$2.39
-1.85%
Mkt Cap $404.01M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 7, 2026 | — | — | — | -$0.01 | -$0.03 | -528.07% | — | — |
| Q4 2025 Dec 18, 2025 | — | — | — | -$0.01 | -$0.25 | -1801.14% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.04 | -$0.01 | +76.53% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.06 | -$0.04 | +33.33% | — | — |
| Q2 2025 Apr 4, 2025 | $206.01K | — | — | -$0.06 | -$0.11 | -83.33% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.16 | -$0.25 | -56.25% | — | — |
| Q3 2024 Aug 28, 2024 | $211.50K | — | — | -$0.51 | -$0.07 | +86.27% | — | — |
| Q2 2024 Jun 5, 2024 | — | — | — | — | $0.04 | — | — | — |
| Q1 2024 Mar 29, 2024 | — | $160.34K | — | -$0.10 | -$0.59 | -513.00% | — | — |
| Q3 2023 Sep 30, 2023 | — | $546.77K | — | — | -$0.57 | — | — | — |
| Q3 2023 Aug 17, 2023 | $960.42K | $1.36M | +41.23% | -$0.26 | -$0.64 | -146.64% | — | — |
| Q1 2023 Mar 31, 2023 | — | $1.43M | — | -$0.49 | -$0.68 | -37.89% | — | — |
| Q4 2022 Dec 31, 2022 | — | -$19.97M | — | — | -$1.29 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | -$19.14M | — | — | -$1.23 | — | — | — |
| Q3 2022 Aug 30, 2022 | $2.53M | $3.87M | +52.74% | -$0.16 | -$0.95 | -494.23% | — | — |
| Q1 2022 Mar 31, 2022 | — | $4.08M | — | — | -$1.00 | — | — | — |
| Q1 2022 Mar 29, 2022 | $12.12M | $5.52M | -54.49% | -$0.34 | -$1.26 | -269.12% | — | — |
| Q4 2021 Nov 12, 2021 | — | $5.44M | — | — | -$1.24 | — | — | — |
| Q3 2021 Aug 31, 2021 | $5.20M | $1.37M | -73.58% | -$0.36 | -$1.13 | -214.96% | — | — |
| Q1 2021 Mar 31, 2021 | — | $1.35M | — | — | -$1.12 | — | — | — |